Abstract Six new lanostane-type triterpenoids, namely leucocontextins S-X (1-6), together with twelve known compounds, were isolated from the fruiting bodies of Ganoderma leucocontextum. Their structures were established by MS and NMR data. 
Introduction
The higher fungi of Ganoderma are documented by many ancient Chinese Medicine books as tonic drugs for their health function. Modern pharmacological researches have illuminated that the effective components of the genus Ganoderma are mainly polysaccharides [1] [2] [3] and triterpenoids [4, 5] . Triterpenoids derived from Ganoderma spp., especially lanostane-type, have been one of the hotspots for a long time and the number of triterpenoids isolated from this genus has exceeded 300 [6] [7] [8] [9] [10] . G. leucocontextum is a special fungus because it is mainly distributed in plateau areas and has rarely been reported for its chemical compositions [6] . In the previous research, we have reported eighteen lanostane triterpenoids from this fungus [10] . In order to further make clear the secondary constituents of G. leucocontextum and comprehend its intrinsic differences from other common species, a further chemical investigation on the fruiting bodies of G. leucocontextum was carried out, which led to the discovery of six new lanostane triterpenoids, along with twelve known ones ( Fig. 1 ). This study has shed light on the similarity of chemical structures between G. leucocontextum and other species, which are mostly lanostane type triterpenoids [11] . All the new compounds were evaluated for their cytotoxicities against human myelogenous leukemia (K562), hepatocellular carcinoma (SMMC-7721) and breast cancer (MCF-7) cells lines.
Results and Discussion
Leucocontextin S (1) was isolated as colorless needles. C NMR data indicated the existence of seven methyls, nine methylenes (one oxygenated), a tetrasubstituted double bond, five methines (two oxygenbonded), five sp 3 quaternary carbons (one oxygenated), and two carbonyls (Tables 1, 2) . The above-mentioned data suggested that compound 1 was quite similar to ganoderiol D (9) [12, 13] , except for an extra hydroxy substituted at C-11 of 1. This difference was confirmed by HMBC correlation of H-11 (d H 4.52)/C-9 (d C 159.1) and 1 H-1 H COSY correlation of H-11/H-12 (d H 1.87, 2.52) (Fig. 2) . The orientation of 11-OH was established as a based on the correlations between H-11 and Me-18/Me-19 in the ROESY spectrum (Fig. 2) . Furthermore, the absolute configurations of C-24 and C-25 was inferred as S and R via comparing with the chemical shifts of ganodermanontriol which had been synthesized in 2011 [14] . In the 13 C NMR data (Table 2) , signals at 79.3 (C-24), 74.2 (C-25) and 67.5 (C-26) were nearly identical with those of ganodermanontriol [79.3 (C-24), 74.0 (C-25), 67.6 (C-26)]. Thus, structure 1 was established as (24S,25R)-11a,24,25,26-tetrahydroxy-5a-lanost-8-ene-3,7-dione.
HREIMS data gave leucocontextin T (2) the same molecular formula as 1 (C 30 H 48 O 6 ). Analysis of the 1D NMR data (Tables 1, 2 ) and HSQC displayed that 2 was an analogue of 11-oxo ganoderiol D (15) [7] , while the carbonyl group at C-7 of 15 was reduced to a hydroxy in 2 (Supporting Information, Figure S12 ). And the orientation of 7-OH was b according to the ROESY correlation of H-7 (d H 4.46)/H-5 (d H 2.10) (Electronic supplementary material, Figure S13 ). Other chiral centers were same with those of 1 by comparison of the NMR data. Therefore, the structure of 2 was decided to be (24S,25R)-7b,24,25,26-tetrahydroxy-5a-lanost-8-ene-3,11-dione.
Leucocontextin U (3) was isolated as white powder. The HRESIMS of 3 showed an ion peak at m/z 507. 1.25) suggested that the orientations of C-3 and C-11 were b and a, respectively. The stereochemistry of other chiral centers of 3 was same with those of 1. Hence, structure of 3 was elucidated to be (24S,25R)-3b,11a,24,25,26-pentahydroxy-5a-lanost-8-en-7-one.
Leucocontextin V (4) had the molecular formula of Therefore, an ether linkage was assigned between C-1 and C-11 based on aforementioned evidences and the degrees of unsaturation [15, 16] . ROESY experiment showed correlations between H-11 (d H 5.36)/Me-18 (d H 0.92) and H-11/Me-19 (d H 1.43), which revealed that the orientation of C-11 was a. The relative configuration of 4 was same with 1 (Supporting Information, Figure S27 ). Consequently, the structure of 4 was determined to be (24S,25R)-1,11a-epoxy-24,25,26-trihydroxy-5a-lanosta- . Analysis of its 1D NMR spectra showed that the structure of compound 5 was similar to ganoleucoin G (7) [6] ( Tables 1, 2) , with the differences being that the carbonyl groups at C-3 and C-11 were reduced to hydroxy groups in 5. Figure S34 ). Thus the structure was defined as 3b,11a,26,27-tetrahydroxy-5a-lanosta-8,24-dien-7-one.
Leucocontextin X (6) gave a molecular ion peak at m/z 656.3188 [M] ? in its HREIMS spectrum, indicating a molecular formula of C 36 H 48 O 11 (13 degrees of Figure S39 ). The absolute configuration of C-3 0 was inferred as S by comparing the carbon chemical shifts of (4-carboxy-3-hydroxy-3-methylbutanoyl)oxy group between 6 and those of ganoleucion L in the same NMR solvent (Supporting Information, Figure S43 ). As a result, the structure of 6 was elucidated as (24E)-29-O-((3S)-4-carboxy-3-hydroxy-3- methylbutanoyl)-3,7,11,15-tetraoxo-5a-lanosta-8,24-dien-26-oic acid. Twelve known lanostane-type triterpeniods, ganoleucoins G (7) [6] and I (8) [6] , ganoderiols D (9) [12] , E (10) [12] , F (18) [12] , H (16) [12] and J (11) [13] , lucialdehyde B (13) [17] , lucidadiol (14) [18] , lucidal (12) [18], 11-oxo ganoderiol D (15) [7] and ganodermanontriol (17) [12, 14] were also obtained from this fungus. Their structures were identified by 1D NMR spectrum as well as comparison with reported data.
Compounds 1-6 were evaluated for inhibitory activities against K562, SMMC-7721 and MCF-7 cell lines. The cytotoxicity was determined by using MTS method. Unfortunately, none of them showed significant activity.
Experimental Section

General Experimental Procedures
Optical rotations were obtained on a JASCO P-1020 digital polarimeter (Horiba, Kyoto, Japan). UV spectra were recorded on a Shimadzu UV-2401PC (Shimadzu, Kyoto, Japan). 1D and 2D NMR spectra were obtained on a Bruker Avance III 600 MHz spectrometer (Bruker Biospin GmbH, Karlsruhe, Germany). HREIMS was measured on Waters Xevo TQ-S and Waters Autospec Premier P776 mass spectrometers (Waters, Milford, MA, USA). HRESIMS were recorded on an Agilent 6200 Q-TOF MS system (Agilent Technologies, Santa Clara, CA, USA). Melting points were measured on an X-4 microscopic melting point meter (Yuhua Instrument Co., Ltd, Gongyi, China). Sephadex LH-20 (Amersham Biosciences, Upssala, Sweden) and silica gel (Qingdao Haiyang Chemical Co., Ltd) were used for column chromatography (CC). Medium Pressure Liquid Chromatography (MPLC) was performed on a Büchi Sepacore System equipping with pump manager C-615, pump modules C-605 and fraction collector C-660 (Büchi Labortechnik AG, Flawil, Switzerland), and columns packed with Chromatorex C-18 (40-75 lm, Fuji Silysia Chemical Ltd., Kasugai, Japan). Preparative High Performance Liquid Chromatography (prep-HPLC) was performed on an Agilent 1260 liquid chromatography system equipped with Zorbax SB-C18 columns (5 lm, 9.4 mm 9 150 mm or 21.2 mm 9 150 mm) and a DAD detector (Agilent Technologies, Santa Clara, CA, USA).
Fungal Material
The fungus G. leucocontextum were collected in Nyingchi, Tibet, China in 2014, and identified by professor Yu-Cheng Dai (Beijing Forestry University). A voucher specimen of G. leucocontextum was deposited in the Herbarium of Kunming Institute of Botany, Chinese Academy of Sciences (No. HFC 20140613).
Extraction and Isolation
The air-dried and powdered fruiting bodies of G. leucocontextum (2.5 kg) was macerated three times with 95 % methanol. The extract was evaporated under reduced pressure and partitioned between EtOAc and water four times to give a crude extract (65 g). The crude extract was subject to MPLC with a stepwise gradient of MeOH/H 2 O (v/v 40:60-100:0) to afford nine fractions (A-I).
Fraction D (10.5 g) was separated by Sephadex LH-20 (MeOH) to give two major subfractions (D1-D2). Subfraction D1 was separated on silica gel CC using a petroleum ether-acetone gradient solvent system (v/v, 4:1-2:1) to obtain three subfractions (D1a-D1c). Subfraction D1a and D1b were separated by Sephadex LH-20 (acetone) to afford three subfractions (D1a1-D1a3 and D1b1-D1b3), respectively. Each part was purified on prep-HPLC (MeCN-H 
Cytotoxicity Assay
The cytotoxicity against K562, SMMC-7721 and MCF-7 cells lines of compounds 1-6 were tested by using MTS method. MTS [3-(4,5-dimethylthiazol-2-yl)-5(3-carboxymethoxyphenyl)-2-(4-sulfopheny)-2H-tetrazolium]is an analogue of MTT [19] , which can be reduced into soluble formazan by succinate dehydrogenase in mitochondria of living cells. Moreover, the optical density value of formazan (490 nm) is proportional to the number of living cells (Electronic supplementary material, Table S1 ).
